At UNIfied, we design glasses to frame people’s true colours and help them display their individuality, encourage self-expression and, ultimately, celebrate their uniqueness. We believe in the power of the individual and in strength in numbers. It is by sharing ideas, experiences and creativity that we will be able to abolish borders and build a UNIted world. Montreal, a unique and colourful city, is the inspiration behind the Unified brand. Incorporating its nuances and vibes was paramount to the design of each model.
UNIfied…to see farther.
Featured model: DUMAS
Distributed by Lanctôt: www.rlanctot.com
EssilorLuxottica Renews License Agreement for Target Optical
EssilorLuxottica announced that it has renewed its licensing agreement with Target Corporation (Target), a Minneapolis-based retailer serving guests at nearly 2,000 stores across the U.S. and at Target.com, for the operation and management of Target Optical within Target stores. The multi-year agreement became effective on February 12, 2023.
Target Optical, one of the leading omnichannel optical retailers in the U.S., provides comprehensive eyecare services for more than 1.5 million Target guests each year. Target Optical offers eye exams delivered by trusted and experienced optometrists and a wide selection of prescription eyewear and sunglasses including Ray-Ban, Oakley, and Transitions.
Target Optical currently has more than 560 locations nationwide in addition to digital offerings at TargetOptical.com.
Source: EssilorLuxottica
Reducing Inflammation to Protect Vision for Diabetic Retinopathy and Premature Infants
Diabetic retinopathy and retinopathy of prematurity are eye diseases that occur when blood vessels grow uncontrollably and leak fluid and blood into the eye, causing vision loss. Inflammation can be a response to this damage and may make the eye disease worse.
Researchers from the Medical College of Georgia have published a study in the journal Cell Death and Disease, showing that a molecule called arginase 1 may interfere with the inflammatory response and reduce damage. Arginase 1 has been previously studied as a potential treatment for certain types of cancer. In this new study, researchers studied mice who had been fed a high-fat diet and developed a condition similar to diabetic retinopathy. When these mice were treated with arginase 1, the mice had less inflammation and exhibited healthier retinas with less leakage.
Currently, the standard treatment for diabetic retinopathy is injections into the eye of a drug called anti-VEGF which reduces blood vessel growth. These treatments can be very effective at slowing progression of the disease but can also be invasive. What is potentially exciting about arginase 1, is that it can be delivered by a less invasive method.
This is encouraging but still early-stage research. More work will have to be done in animal models before this potential treatment can be tested in humans in a clinical trial. We look forward to learning more as the research progresses.
Dear Men, Life is Too Short to Wear Boring Glasses!
Calling all men: the new collection by Glossi has everything you are looking for.
Comfort, stability, uniqueness, and boldness all wrapped into four new models.
Featured model: Eric
Check out the collection: www.georgesetphina.com
Lila is Full of Character
Woodys presents Lila, an Italian acetate design with volumes and stronger milled rods with more character. The model features German 5-axis hinges and CR39 lenses with high UVA and UVB protection produced by Carl Zeiss to guarantee the best visual experience.
Distributed by Mood Eyewear: www.moodeyewear.com

